Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A glucagon-like Peptide-1 receptor agonist lowers weight by modulating the structure of gut microbiota
The injectable drugs popularity soared when it was discovered that weight loss was an added bonus
doi: 10.3389/fphys.2019.00272 Received 05 November 2018 Accepted 28 February 2019 Published 04 April 2019 Volume 10 - 2019 Edited by Christopher Huang, University of Cambridge, United Kingdom Reviewed by Houzao Chen, Chinese Academy of Medical Sciences, China
Despite their significant clinical potential, they are associated with certain limitations, including suboptimal pharmacokinetics and patient adherence challenges, necessitating the development of advanced drug delivery systems to optimize efficacy and improve compliance
US$ 27.71
US$ 21.32
US$ 22.92
US$ 26.53
US$ 20.63
